All SMA patients lack a functional SMN1 gene and retain one or more copies of the SMN2 gene, which produces insufficient amounts of the SMN protein leading to motor neuron loss, skeletal muscle weakness, аtrорhy and multiorgan abnormalities2,3. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.